Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13776
Country/Region: Mozambique
Year: 2018
Main Partner: Center for Collaboration in Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $8,250,004 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,011,905
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $1,011,904
Care: Pediatric Care and Support (PDCS) $233,516
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $778,386
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $466,134
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $3,969,773
Treatment: Pediatric Treatment (PDTX) $778,386
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 77
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 163
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 77
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 78
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 163
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 403
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 40
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 40
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 323
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 403
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 484
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 566
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 163
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 243
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 163
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 243
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 163
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 243
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 1,910
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 1,661
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 2,389
GEND_GBV Number of people receiving post-GBV care 2019 4,051
HTS_TST <1, Unknown Sex, Negative 2019 2,504
HTS_TST 1-9, Unknown Sex, Negative 2019 15,968
HTS_TST 10-14, Female, Negative 2019 3,150
HTS_TST 10-14, Male, Negative 2019 2,774
HTS_TST 15-19, Female, Negative 2019 1,858
HTS_TST 15-19, Male, Negative 2019 751
HTS_TST 20-24, Female, Negative 2019 4,029
HTS_TST 20-24, Male, Negative 2019 2,201
HTS_TST 25-29, Female, Negative 2019 4,423
HTS_TST 25-29, Female, Negative 2019 389
HTS_TST 25-29, Female, Negative 2019 2,222
HTS_TST 25-29, Female, Negative 2019 2,893
HTS_TST 25-29, Female, Negative 2019 727
HTS_TST 25-29, Female, Negative 2019 65
HTS_TST 25-29, Male, Negative 2019 621
HTS_TST 25-29, Male, Negative 2019 1,450
HTS_TST 25-29, Male, Negative 2019 2,055
HTS_TST 25-29, Male, Negative 2019 530
HTS_TST 25-29, Male, Negative 2019 65
HTS_TST 30-34, Female, Negative 2019 4,423
HTS_TST 30-34, Female, Negative 2019 389
HTS_TST 30-34, Female, Negative 2019 2,222
HTS_TST 30-34, Female, Negative 2019 2,893
HTS_TST 30-34, Female, Negative 2019 727
HTS_TST 30-34, Female, Negative 2019 65
HTS_TST 30-34, Male, Negative 2019 621
HTS_TST 30-34, Male, Negative 2019 1,450
HTS_TST 30-34, Male, Negative 2019 2,055
HTS_TST 30-34, Male, Negative 2019 530
HTS_TST 30-34, Male, Negative 2019 65
HTS_TST 35-39, Female, Negative 2019 65
HTS_TST 35-39, Female, Negative 2019 4,423
HTS_TST 35-39, Female, Negative 2019 389
HTS_TST 35-39, Female, Negative 2019 2,222
HTS_TST 35-39, Female, Negative 2019 2,893
HTS_TST 35-39, Female, Negative 2019 727
HTS_TST 35-39, Male, Negative 2019 65
HTS_TST 35-39, Male, Negative 2019 621
HTS_TST 35-39, Male, Negative 2019 1,450
HTS_TST 35-39, Male, Negative 2019 2,055
HTS_TST 35-39, Male, Negative 2019 530
HTS_TST 40-49, Female, Negative 2019 65
HTS_TST 40-49, Female, Negative 2019 4,423
HTS_TST 40-49, Female, Negative 2019 389
HTS_TST 40-49, Female, Negative 2019 2,222
HTS_TST 40-49, Female, Negative 2019 2,893
HTS_TST 40-49, Female, Negative 2019 727
HTS_TST 40-49, Male, Negative 2019 65
HTS_TST 40-49, Male, Negative 2019 621
HTS_TST 40-49, Male, Negative 2019 1,450
HTS_TST 40-49, Male, Negative 2019 2,055
HTS_TST 40-49, Male, Negative 2019 530
HTS_TST 50+, Female, Negative 2019 1,545
HTS_TST 50+, Male, Negative 2019 1,139
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 149,054
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 3,461
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 9,760
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 21
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 487
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 3,138
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 619
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 542
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 457
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 187
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 999
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 534
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 374
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 283
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 228
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 2,028
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 239
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 225
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 30
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 20
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 75
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 34
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 75
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 81
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 1,473
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 63
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 44
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 241
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 119
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 297
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 436
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 450
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 4,329
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 1,329
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 990
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 1,161
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 413
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 2,376
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 1,055
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 968
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 911
HTS_TST_POS 15-19, Female, Positive 2019 153
HTS_TST_POS 15-19, Male, Positive 2019 59
HTS_TST_POS 20-24, Female, Positive 2019 328
HTS_TST_POS 20-24, Male, Positive 2019 178
HTS_TST_POS 25-29, Female, Positive 2019 472
HTS_TST_POS 25-29, Female, Positive 2019 30
HTS_TST_POS 25-29, Female, Positive 2019 303
HTS_TST_POS 25-29, Female, Positive 2019 238
HTS_TST_POS 25-29, Female, Positive 2019 67
HTS_TST_POS 25-29, Female, Positive 2019 18
HTS_TST_POS 25-29, Male, Positive 2019 51
HTS_TST_POS 25-29, Male, Positive 2019 200
HTS_TST_POS 25-29, Male, Positive 2019 167
HTS_TST_POS 25-29, Male, Positive 2019 53
HTS_TST_POS 25-29, Male, Positive 2019 18
HTS_TST_POS 30-34, Female, Positive 2019 472
HTS_TST_POS 30-34, Female, Positive 2019 30
HTS_TST_POS 30-34, Female, Positive 2019 303
HTS_TST_POS 30-34, Female, Positive 2019 238
HTS_TST_POS 30-34, Female, Positive 2019 67
HTS_TST_POS 30-34, Female, Positive 2019 18
HTS_TST_POS 30-34, Male, Positive 2019 18
HTS_TST_POS 30-34, Male, Positive 2019 51
HTS_TST_POS 30-34, Male, Positive 2019 200
HTS_TST_POS 30-34, Male, Positive 2019 167
HTS_TST_POS 30-34, Male, Positive 2019 53
HTS_TST_POS 35-39, Female, Positive 2019 18
HTS_TST_POS 35-39, Female, Positive 2019 472
HTS_TST_POS 35-39, Female, Positive 2019 30
HTS_TST_POS 35-39, Female, Positive 2019 303
HTS_TST_POS 35-39, Female, Positive 2019 238
HTS_TST_POS 35-39, Female, Positive 2019 67
HTS_TST_POS 35-39, Male, Positive 2019 18
HTS_TST_POS 35-39, Male, Positive 2019 51
HTS_TST_POS 35-39, Male, Positive 2019 200
HTS_TST_POS 35-39, Male, Positive 2019 167
HTS_TST_POS 35-39, Male, Positive 2019 53
HTS_TST_POS 40-49, Female, Positive 2019 18
HTS_TST_POS 40-49, Female, Positive 2019 472
HTS_TST_POS 40-49, Female, Positive 2019 30
HTS_TST_POS 40-49, Female, Positive 2019 303
HTS_TST_POS 40-49, Female, Positive 2019 238
HTS_TST_POS 40-49, Female, Positive 2019 67
HTS_TST_POS 40-49, Male, Positive 2019 18
HTS_TST_POS 40-49, Male, Positive 2019 51
HTS_TST_POS 40-49, Male, Positive 2019 200
HTS_TST_POS 40-49, Male, Positive 2019 167
HTS_TST_POS 40-49, Male, Positive 2019 53
HTS_TST_POS 50+, Female, Positive 2019 126
HTS_TST_POS 50+, Male, Positive 2019 91
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 369
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 1,038
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 104
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 41
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 89
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 67
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 82
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 205
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 65
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 48
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 159
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 54
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 322
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 141
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 133
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 125
PMTCT_ART Already on ART at beginning of current pregnancy 2019 3,289
PMTCT_ART New on ART 2019 3,354
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 6,643
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 37,990
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 5,368
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 1,346
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 6,714
PMTCT_EID Sum of Infant Age disaggregates 2019 6,714
PMTCT_STAT 25-29, Female 2019 17,206
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 214
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 16,439
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 513
PMTCT_STAT 30-34, Female 2019 296
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 214
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 78
PMTCT_STAT 35-39, Female 2019 215
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 214
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 79
PMTCT_STAT 40-49, Female 2019 206
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 205
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 79
PMTCT_STAT By Age (Numerator): 10-14 2019 99
PMTCT_STAT By Age (Numerator): 15-19 2019 8,654
PMTCT_STAT By Age (Numerator): 20-24 2019 11,285
PMTCT_STAT By Number of known positives: 15-19 2019 46
PMTCT_STAT By Number of known positives: 20-24 2019 186
PMTCT_STAT By Number of new negative: 10-14 2019 98
PMTCT_STAT By Number of new negative: 15-19 2019 8,415
PMTCT_STAT By Number of new negative: 20-24 2019 10,760
PMTCT_STAT By Number of new positives: 15-19 2019 117
PMTCT_STAT By Number of new positives: 20-24 2019 311
PMTCT_STAT Number of new ANC and L&D clients 2019 39,023
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 37,990
PMTCT_STAT_den 25-29, Female 2019 5,725
PMTCT_STAT_den 30-34, Female 2019 6,192
PMTCT_STAT_den 35-39, Female 2019 6,059
PMTCT_STAT_den 40-49, Female 2019 6,072
PMTCT_STAT_den By Age (Denominator): <15-19 2019 5,616
PMTCT_STAT_den By Age (Denominator): 10-14 2019 80
PMTCT_STAT_den By Age (Denominator): 20-24 2019 9,279
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 53
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 1,059
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 76
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 1,327
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 2,594
TB_PREV By Age/Sex (Numerator): <15, Female 2019 261
TB_PREV By Age/Sex (Numerator): <15, Male 2019 226
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 6,235
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 3,438
TB_PREV IPT, Life-long ART, Already, Positive 2019 2,033
TB_PREV IPT, Life-long ART, New, Positive 2019 8,127
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 10,160
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 13,543
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 348
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 318
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 8,160
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 4,714
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 2,709
TB_PREV_den IPT, Life-long ART, New, Positive 2019 10,835
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 187
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 3,140
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 250
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 4,244
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 7,821
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 7,821
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 221
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 3,067
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 276
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 4,263
TX_CURR 25-29, Female, Positive 2019 20,047
TX_CURR 25-29, Male, Positive 2019 8,129
TX_CURR 30-34, Female, Positive 2019 20,047
TX_CURR 30-34, Male, Positive 2019 8,129
TX_CURR 35-39, Female, Positive 2019 20,047
TX_CURR 35-39, Male, Positive 2019 8,129
TX_CURR 40-49, Female, Positive 2019 20,047
TX_CURR 40-49, Male, Positive 2019 8,128
TX_CURR Age/Sex: <1 2019 132
TX_CURR Age/Sex: <1-9 2019 3,723
TX_CURR Age/Sex: 10-14 Female 2019 1,910
TX_CURR Age/Sex: 10-14 Male 2019 1,823
TX_CURR Age/Sex: 15-19 Female 2019 2,803
TX_CURR Age/Sex: 15-19 Male 2019 920
TX_CURR Age/Sex: 20-24 Female 2019 9,621
TX_CURR Age/Sex: 20-24 Male 2019 1,134
TX_CURR Age/Sex: 50+ Female 2019 13,721
TX_CURR Age/Sex: 50+ Male 2019 9,392
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 157,897
TX_CURR Sum of age/sex disaggregates 2019 3,723
TX_NEW 25-29, Female, Positive 2019 1,567
TX_NEW 25-29, Male, Positive 2019 1,072
TX_NEW 30-34, Female, Positive 2019 1,567
TX_NEW 30-34, Male, Positive 2019 1,072
TX_NEW 35-39, Female, Positive 2019 1,566
TX_NEW 35-39, Male, Positive 2019 1,072
TX_NEW 40-49, Female, Positive 2019 1,568
TX_NEW 40-49, Male, Positive 2019 1,070
TX_NEW Breastfeeding status 2019 50
TX_NEW By Age/Sex: <1 2019 260
TX_NEW By Age/Sex: 1-9 2019 740
TX_NEW By Age/Sex: 10-14 Female 2019 212
TX_NEW By Age/Sex: 10-14 Male 2019 192
TX_NEW By Age/Sex: 15-19 Female 2019 542
TX_NEW By Age/Sex: 15-19 Male 2019 108
TX_NEW By Age/Sex: 20-24 Female 2019 1,662
TX_NEW By Age/Sex: 20-24 Male 2019 258
TX_NEW By Age/Sex: 50+ Female 2019 736
TX_NEW By Age/Sex: 50+ Male 2019 692
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 15,928
TX_NEW Pregnancy status 2019 1,740
TX_NEW Sum of Age/Sex disaggregates 2019 4,402
TX_PVLS <15, Undocumented Test Indication, Female 2019 2,823
TX_PVLS <15, Undocumented Test Indication, Male 2019 1,492
TX_PVLS 15+, Undocumented Test Indication, Female 2019 71,618
TX_PVLS 15+, Undocumented Test Indication, Male 2019 34,812
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 110,745
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 570
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 245
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 10,060
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 4,085
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 14,985
TX_RET Numerator by Status: Breastfeeding 2019 1,001
TX_RET Numerator by Status: Pregnant 2019 528
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 16,701
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 637
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 276
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 11,100
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 4,662
TX_RET_den Denominator by Status: Breastfeeding 2019 1,313
TX_RET_den Denominator by Status: Pregnant 2019 463
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 157,897
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 5,017
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 4,511
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 101,855
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 42,679
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 1,486
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 1,486
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 107,356
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 12,618
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 34,723
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 3,145
Cross Cutting Budget Categories and Known Amounts Total: $4,966,730
Key Populations: MSM and TG $100,000
Training of health workers and community outreach workers
Key Populations: Sex Workers $100,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Gender: Gender Based Violence (GBV) $252,520
GBV Prevention
Human Resources for Health $2,338,680
Motor Vehicles: Purchased $100,000
Food and Nutrition: Policy, Tools, and Service Delivery $186,000
Renovation $1,739,530
Condoms: Policy, Tools, and Services $150,000